Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Enhancing Telemedicine for T2D

Pilot Study Enhancing Telemedicine Care Delivery for Adults With Complex Type 2 Diabetes

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this pilot clinical trial is to assess feasibility of an intervention to deliver comprehensive, high-quality diabetes care through telemedicine among adults with type 2 diabetes who use insulin and have multiple chronic health conditions. The main question it aims to answer is: Is an enhanced telemedicine intervention for type 2 diabetes compared to usual telemedicine care feasible? Researchers will compare the enhanced telemedicine intervention to usual telemedicine care to see if there are differences in patient satisfaction or preliminary clinical outcomes. Participants will complete 2-3 telemedicine diabetes care visits over approximately 6 months, as well as complete survey measures with each diabetes care visit. Patients in the intervention group will also receive additional support, including pre-visit preparation phone calls, diabetes self-management education and support aligned with their visits, and post-visit follow-up calls.

Who May Be Eligible (Plain English)

Who May Qualify: - adults 18 years or older - Diagnosis of type 2 diabetes based on abbreviated ICD-10 code E11.X in medical record or self-report - HbA1c greater than or equal to 8% based on most recent value at time of recruitment - Patients must own or have access to a smart phone, tablet, or home computer with data or internet connection that allows access to video-based visits - Patient must use insulin - Patients must have \>2 comorbid chronic health conditions - Be able to provide willing to sign a consent form - Reside in Pennsylvania Who Should NOT Join This Trial: - Age over 80 based on date of birth in electronic medical record - Visit with an endocrinologist in the prior 1 years - Dementia, ESRD, malignancy based on abbreviated ICD-10 codes below in medical record or self-report of associated condition - Dementia: A81.0x, F01.5x, F02.8x, F03.9x, F10.27, F10.97, F13.27, F13.97, F18.97, F19.17, F19.27, F19.97, G30.x, G31.0x, G31.1, G31.83, G31.85 - Malignancy, except non-melanoma skin cancer: C00.x-C14.x, C15.x-C26.x, C3x.xx, C40.xx-C41.x, C43.x, C4A.xx, C45.x-C49.xx, C50.xxx, C51.x-C58, C60.x-C63.x, C64.x- C68.x, C69.xx-C72.x, C73-C76.x, C7A.xx, C80.xx-C96.x (except C90.x1, C91.x1, C92.x1, C93.x1, C94.x1, C95.x1) - ESRD N18.6 - Type 1, gestational, or other diabetes based on abbreviated ICD-10 codes below in medical record or self-report of associated condition - Type 1 diabetes: E10.X - Gestational diabetes: O24.X, E08.X - Other diabetes: E09.X, E13.2 - Pregnant or planning to become pregnant in next 6 months - Currently enrolled in another diabetes management intervention study Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * adults 18 years or older * Diagnosis of type 2 diabetes based on abbreviated ICD-10 code E11.X in medical record or self-report * HbA1c greater than or equal to 8% based on most recent value at time of recruitment * Patients must own or have access to a smart phone, tablet, or home computer with data or internet connection that allows access to video-based visits * Patient must use insulin * Patients must have \>2 comorbid chronic health conditions * Be able to provide informed consent * Reside in Pennsylvania Exclusion criteria: * Age over 80 based on date of birth in electronic medical record * Visit with an endocrinologist in the prior 1 years * Dementia, ESRD, malignancy based on abbreviated ICD-10 codes below in medical record or self-report of associated condition * Dementia: A81.0x, F01.5x, F02.8x, F03.9x, F10.27, F10.97, F13.27, F13.97, F18.97, F19.17, F19.27, F19.97, G30.x, G31.0x, G31.1, G31.83, G31.85 * Malignancy, except non-melanoma skin cancer: C00.x-C14.x, C15.x-C26.x, C3x.xx, C40.xx-C41.x, C43.x, C4A.xx, C45.x-C49.xx, C50.xxx, C51.x-C58, C60.x-C63.x, C64.x- C68.x, C69.xx-C72.x, C73-C76.x, C7A.xx, C80.xx-C96.x (except C90.x1, C91.x1, C92.x1, C93.x1, C94.x1, C95.x1) * ESRD N18.6 * Type 1, gestational, or other diabetes based on abbreviated ICD-10 codes below in medical record or self-report of associated condition * Type 1 diabetes: E10.X * Gestational diabetes: O24.X, E08.X * Other diabetes: E09.X, E13.2 * Pregnant or planning to become pregnant in next 6 months * Currently enrolled in another diabetes management intervention study

Treatments Being Tested

OTHER

Enhanced Telemedicine for Type 2 Diabetes

Telemedicine-based endocrinology specialty care for type 2 diabetes with multidisciplinary diabetes care team support including pre-visit preparation, in-visit support and self-management education, and post-visit follow-up.

OTHER

Usual Telemedicine Endocrinology Care for T2D

Routine telemedicine-based endocrinology specialty care for type 2 diabetes, generally consisting of synchronous virtual visit with an endocrinologist and additional support including self-management education on an individualized basis.

Locations (1)

University of Pittsburgh
Pittsburgh, Pennsylvania, United States